aTyr Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -387 | -383 | -175 | -388 |
EBITDA | -20,313 | -15,390 | -15,820 | -17,755 |
EBIT | -20,700 | -15,773 | -15,819 | -18,143 |
Net Income | -19,531 | -14,880 | -14,967 | -17,259 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,903 | -15,420 | -13,157 | -13,173 |
Cash | 17,220 | 10,362 | 11,055 | 11,458 |
Basic Shares | 90,120 | 86,485 | 82,724 | 75,801 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $235 | $353 | $10,386 | $0 |
Gross Profit | 235 | 353 | 8,691 | -1,304 |
EBITDA | -66,374 | -52,178 | -44,709 | -32,473 |
EBIT | -67,914 | -54,919 | -46,404 | -33,777 |
Net Income | -64,023 | -50,389 | -45,338 | -33,768 |
Net Change In Cash | 235 | 353 | 10,386 | 0 |
Free Cash Flow | -69,184 | -37,436 | -43,527 | -33,267 |
Cash | 11,055 | 22,544 | 9,981 | 2,336 |
Basic Shares | 74,261 | 53,606 | 28,419 | 19,080 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.22 |
2025-03-31 | -$0.17 |
2024-12-31 | -$0.18 |
2024-09-30 | -$0.22 |
